SuperworthMSA Safety MSA
- Market cap
- $7B
- PE
- 22.7×
- 10y median 36.3×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 3.6×
- EV/EBIT
- 18.0×
- Revenue, 12 months
- $1.9B
- +6% on a year ago
- Net margin
- 16.1%
- Free cash flow yield
- 5.0%
MSA Safety trades at 22.7× trailing earnings, cheaper than 94% of the last ten years. Revenue was $1.9B over the last twelve months, up 6% on a year earlier with a 16% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $446.7M+17% | $495.4M+12% | $413.3M+4% | $462.5M+3% | $432.7M−3% | $499.7M+1% | $421.3M+2% | $474.1M+3% | $468.4M+8% | $510.9M+2% | $463.6M+10% | $503.3M+6% | |
| Cost of revenue | $228M+7% | $257.2M+5% | $217.8M+0% | $239.4M+3% | $225.2M−1% | $265.3M+3% | $227.9M+5% | $253.4M+6% | $250.8M+11% | $271.5M+2% | $244.1M+7% | $254M+0% |
| Gross profit | $218.8M+29% | $238.2M+21% | $195.5M+8% | $223M+4% | $207.5M−5% | $234.4M−2% | $193.4M−1% | $220.7M−1% | $217.6M+5% | $239.4M+2% | $219.6M+14% | $249.3M+13% |
| R&D | $17.7M+23% | $19.1M+36% | $15.9M+5% | $17.1M+7% | $16.7M−6% | $16.8M−12% | $15.7M−2% | $17M−0% | $16.5M−1% | $16.2M−4% | $16.4M+4% | $19.2M+13% |
| SG&A | $102.2M+24% | $107M+17% | $94.2M+3% | $105.1M+9% | $95.1M−7% | $100.4M−6% | $94M−0% | $112.1M+7% | $102.9M+8% | $105.4M+5% | $107.7M+15% | $114.1M+2% |
| $94.1M+46% | $102.3M+45% | $80.1M | $99.9M+5% | $91.5M−3% | $117.6M+15% | $77.8M−3% | $85.9M−14% | $94.3M+3% | $113.9M−3% | $93M+20% | $112M+30% | |
| Interest expense | $12.5M+110% | $9.6M+28% | $10.7M−6% | $9.7M−27% | $9.2M−27% | $7.3M−24% | $6.8M−36% | $8.1M−16% | $8.4M−8% | $8.4M+15% | $7.7M+13% | $8M−2% |
| Pre-tax income | $87.7M+44% | $99.3M+44% | $75.6M | $94.4M+8% | $88.2M+1% | $116.8M+18% | $77.9M+3% | $82.7M−12% | $92.5M+5% | $113.2M−3% | $93M+19% | $111.4M+35% |
| $22.4M+42% | $22.9M+30% | $17.5M−79% | $22.2M+9% | $21.5M−4% | $28.9M+26% | $18.3M+5% | $20M−10% | $22.8M+6% | $26.3M−9% | $21.7M+18% | $25.2M+26% | |
| Net income | $65.3M+45% | $76.4M+48% | $58.1M | $72.2M+8% | $66.6M+2% | $87.9M+15% | $59.6M+3% | $62.8M−13% | $69.6M+4% | $86.9M−1% | $71.3M+20% | $86.2M+37% |
| $1.65+45% | $1.93+47% | $1.47 | $1.83+8% | $1.69+2% | $2.22+15% | $1.51+3% | $1.59−13% | $1.77+5% | $2.21−1% | $1.83+21% | $2.23+40% | |
| 39.5M+0% | 39.6M+1% | 39.6M+1% | 39.5M+0% | 39.5M+0% | 39.5M−0% | 39.5M−0% | 39.4M−1% | 39.3M−1% | 39.2M−1% | 39M−1% | 38.7M−2% |
Gross profit: 23 periods, Q2 FY09 to Q4 FY14: not printed by the filing, worked out from its own lines.
Operating income: 24 periods, Q2 FY09 to Q1 FY15: not printed by the filing, worked out from its own lines.
EPS, diluted: 11 periods, Q4 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 13 periods, Q4 FY10 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY17 and Q4 FY21: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY23: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Medical - Instruments & Supplies nearest MSA Safety's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| MSAMSA Safety | $7B | 22.7× | 36.3× | 3.6× | +6% | 16.1% | |
| MMSIMerit Medical Systems | $5.6B | 38.6× | 57.5× | 3.5× | +10% | 9.2% | |
| HAEHaemonetics | $5.4B | 58.1× | 51.6× | 4.0× | +0% | 7.1% | |
| PODDInsulet | $10.3B | 27.9× | 63.0× | 3.4× | +29% | 12.3% | |
| VNTVontier | $4.6B | 14.3× | 13.5× | 1.5× | +1% | 11.3% | |
| GMEDGlobus Medical | $10.9B | 20.8× | 37.4× | 3.5× | +20% | 17.0% | |
| ALGNAlign Technology | $11B | 26.9× | 43.3× | 2.7× | +4% | 10.0% | |
| BMIBadger Meter | $4.4B | 35.3× | 47.6× | 5.0× | −2% | 14.3% | |
| COOCooper Companies | $11.6B | 20.9× | 40.2× | 2.7× | +5% | 13.5% | |
| ICUIICU Medical | $4.2B | 141× | 57.8× | 1.9× | −9% | 1.4% | |
| PENPenumbra | $12.8B | 79.7× | 197× | 8.5× | +18% | 10.7% | |
| Peer median | $8B | 31.6× | 49.6× | 3.4× | +5% | 11.0% |
Investors who own it
Investors we follow who held MSA Safety at the end of Jun 30, 2026, from their 13F filings.
- Ruane, Cunniff & GoldfarbRuane, Cunniff & Goldfarb (Sequoia Fund)4.7% of portfoliotrimmed
- François RochonGiverny Capital1.0% of portfolionew
More on MSA Safety
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #10of 80Medical instruments and supplies stocks with the highest profit margins
- #3of 23Medical instruments and supplies stocks cheapest against their own PE history
Its groups
About
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .